Literature DB >> 16362545

The effect of hormone replacement therapy cessation on heart rate variability in postmenopausal women.

Amir Weissman1, Lior Lowenstein, Michal Porat, Adam Geva, Yaron Rosenstein.   

Abstract

Heart rate variability showed no statistically significant changes in the time, frequency or complexity measurements either before or following cessation of hormone replacement therapy in healthy postmenopausal women.

Entities:  

Mesh：

Year:  2005        PMID： 16362545     DOI： 10.1007/s10286-005-0295-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


  18 in total

1.  Approximate entropy as a measure of system complexity.

Authors:  S M Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Autonomic and cardiovascular function in postmenopausal women: the effects of estrogen versus combination therapy.

Authors:  Noha H Farag; Richard A Nelesen; Barbara L Parry; Jose S Loredo; Joel E Dimsdale; Paul J Mills
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

Review 3.  Heart rate variability and its sympatho-vagal modulation.

Authors:  F Lombardi; A Malliani; M Pagani; S Cerutti
Journal:  Cardiovasc Res       Date:  1996-08       Impact factor: 10.787

4.  Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes.

Authors:  J M Evans; M G Ziegler; A R Patwardhan; J B Ott; C S Kim; F M Leonelli; C F Knapp
Journal:  J Appl Physiol (1985)       Date:  2001-12

Review 5.  Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function.

Authors:  X J Du; R A Riemersma; A M Dart
Journal:  Cardiovasc Res       Date:  1995-08       Impact factor: 10.787

6.  Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.

Authors:  N Montano; T G Ruscone; A Porta; F Lombardi; M Pagani; A Malliani
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Authors: 
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

9.  Gender- and age-related differences in heart rate dynamics: are women more complex than men?

Authors:  S M Ryan; A L Goldberger; S M Pincus; J Mietus; L A Lipsitz
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
View more
  1 in total

1.  Interaction between cardiovascular autonomic control and sex hormones in perimenopausal women under menopausal hormone therapy.

Authors:  Anton R Kiselev; Irina W Neufeld; Irina V Bobyleva; Mikhail D Prokhorov; Anatoly S Karavaev
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.